Last reviewed · How we verify

NCT05533996: BFIors

Body Fat Index for Obstetric Risk Stratification

Status unknown NA Last updated 13 October 2022
What this trial tests

NA trial testing ultrasound in Gestational Diabetes in 206 participants. Status unknown.

Timeline
1 March 2023
Primary endpoint
1 February 2024
1 June 2024

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment206
Start date1 March 2023
Primary completion1 February 2024
Estimated completion1 June 2024

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 45, female only, with Gestational Diabetes or Pre-Eclampsia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary Outcome:- GDM Diagnosis Secondary Outcomes:- Pre-eclampsia diagnosis. Cesarean section delivery due to labor dystocia defined as protracted or arrested progress of labor using labor partogram.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ultrasound

Trials testing the same drug.

Other recruiting trials for Gestational Diabetes

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05533996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing